首页|老年危重症患者使用注射用头孢哌酮钠舒巴坦钠后发生肾功能亢进的危险因素分析

老年危重症患者使用注射用头孢哌酮钠舒巴坦钠后发生肾功能亢进的危险因素分析

扫码查看
目的:探讨老年危重症患者使用注射用头孢哌酮钠舒巴坦钠后发生肾功能亢进(ARC)的危险因素。方法:回顾性分析2018-2022 年该院收治的 286 例老年患者的住院信息,根据患者是否发生ARC将其分为ARC组 97 例、对照组 189 例。采用Logistic回归分析筛查ARC发生相关因素,采用受试者工作特征曲线(ROC曲线)分析危险因素对ARC的预测作用。结果:(1)研究对象的ARC发生率为 33。92%,ARC组患者年龄、白细胞计数、尿素氮水平、肌酐水平和SOFA评分显著低于对照组,嗜酸性细胞数、肌酐清除率、肾小球滤过率、颅脑外伤史病例数、并发症数量、发生全身炎症反应综合征(SIRS)病例数显著高于对照组,重症监护室(ICU)治疗时间显著长于对照组,差异均有统计学意义(P<0。05)。(2)ARC组患者中位稳态谷浓度显著低于对照组(5。36 μmol/mL vs。14。12 μmol/mL),差异有统计学意义(χ2 = 10。182,P<0。05);ARC 组患者的治疗有效率显著低于对照组[38。14%(37/97)vs。56。08%(106/189)],差异有统计学意义(χ2 =8。662,P<0。05)。(3)Logistic回归分析结果显示,颅脑外伤史、并发症数量、SOFA评分、SIRS占比与ARC发生呈正相关,年龄与ARC发生呈负相关。(4)ROC曲线结果显示,使用年龄、颅脑外伤史和SOFA评分的预测效果较好。结论:低龄、有颅脑外伤史和SOFA评分较低的老年危重症患使用注射用头孢哌酮钠舒巴坦钠后更容易发生ARC,该类患者在治疗过程中应综合评估ARC发生风险,对治疗方案及时调整。
Risk Factors of Augmented Renal Clearance in Critically-Ill Elderly Patients Administered with Cefoperazone Sodium and Sulbactam Sodium for Injection
OBJECTIVE:To probe into the risk factors of augmented renal clearance(ARC)in critically-ill elderly patients administered with cefoperazone sodium and sulbactam sodium for injection.METHODS:The hospitalization information of 286 elderly patients admitted into the hospital from 2018 to 2022 was retrospectively analyzed,all patients were divided into 97 cases in the ARC group and 189 cases in the control group according to whether to develop ARC.Logistic regression analysis was used to screen factors related to the occurrence of ARC,and receiver operating characteristic curve(ROC curve)was used to analyze the predictive effect of risk factors on ARC.RESULTS:(1)The incidence of ARC of the research objects was 33.92%,the patients'age,white blood cell count,urea nitrogen,creatinine and SOFA score of the ARC group were significantly lower than those of the control group,the number of eosinophils,creatinine clearance rate,glomerular filtration rate,number of patients with craniocerebral trauma history,number of complications and number of patients with systemic inflammatory response syndrome(SIRS)of the ARC group were significantly higher than those of the control group,the ICU treatment time of the ARC group was significantly longer than that of the control group,with statistically significant differences(P<0.05).(2)The median steady-state valley concentration of the ARC group was significantly lower than that of the control group(5.36 μmol/mL vs.14.12 μmol/mL),with statistically significant difference(χ2=10.182,P<0.05);the treatment effective rate of the ARC group was significantly lower than that of the control group[38.14%(37/97)vs.56.08%(106/189)],with statistically significant difference(χ2=8.662,P<0.05).(3)The results of Logistic regression analysis indicated that craniocerebral trauma history,number of complications,SOFA score and proportion of SIRS were positively associated with the occurrence of ARC,and age was negatively associated with the occurrence of ARC.(4)The results of ROC curve indicated that age,craniocerebral trauma history and SOFA score had better predictive effects.CONCLUSIONS:Critically-ill elderly patients with lower age,craniocerebral trauma history and lower SOFA scores are more likely to develop ARC after administered with cefoperazone sodium and sulbactam sodium for injection,and the risk of ARC should be comprehensively assessed during the treatment of this group of patients,and the therapeutic regimen should be adjusted in time.

ElderlyCritically illCefoperazone sodium and sulbactam sodium for injectionAugmented renal clearance

王友芳、李兴超、朱晓松、刘清敏、张建国、杨淑红、相然、张蒙蒙、车峰远

展开 >

临沂市人民医院重症医学科,山东 临沂 276002

临沂市人民医院科研科,山东 临沂 276002

临沂市人民医院感染管理部,山东 临沂 276002

临沂市人民医院护理部,山东 临沂 276002

临沂市人民医院运营管理部,山东 临沂 276002

临沂市人民医院神经内科,山东 临沂 276002

展开 >

老年 重症 注射用头孢哌酮钠舒巴坦钠 肾功能亢进

国家自然科学基金青年基金山东省自然科学基金青年基金山东省医务职工科技创新计划项目

82003435ZR2020QH332SDYWZGKCJH2022077

2024

中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
年,卷(期):2024.24(2)
  • 15